Treat to Target in Rheumatic Diseases: Rationale and Results: 1ed

Price:

NPR 15,437.00


Treat to Target in Rheumatic Diseases: Rationale and Results: 1ed

Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover “Treat to Target in Rheumatic Diseases” with a focus on rationale and results.

NPR 15,437.00 15437.0 NPR NPR 17,152.00

NPR 17,152.00


  • Author
  • Pages
  • Pages 0
  • Year
  • ISBN
  • Publisher
  • Language
  • Edition
  • Weight
  • Dimensions
  • Binding

This combination is not available.

Share :

Treat to Target in Rheumatic Diseases: Rationale and Results: 1ed

About the Author 

Daniel Aletaha is a consultant rheumatologist at the Medical University of Vienna and a renowned scientist in outcomes research, clinical trials, and translational research in rheumatoid arthritis and other inflammatory rheumatic diseases. He received academic degrees from the Medical University in Vienna, Duke University in North Carolina, and Danube University Krems. Daniel has spent more than two years at the National Institutes of Health in Bethesda, Maryland. Daniel Aletaha is a highly cited author of the field of rheumatology and author of more than 200 publications. He is also associate editor of Arthritis and Rheumatology and RMD Open, and editorial board member of a number of rheumatology specialty journals.

Book
Author Aletaha
Pages 0
Year 2019
ISBN 9780323678964
Publisher Elsevier
Language English
Uncategorized
Edition 1/e
Weight 390 g
Dimensions 15.2 x 22.9 x 1 cm
Binding Hardcover